The clinical trials market in Singapore has doubled in size since 1998 when PPD opened an office in the country. PPD has built sound relationships with district hospitals to recruit qualified investigators and ensure speedy patient enrollment for clinical trials.
Singapore offers one of the fastest startup times in Asia; a cost-effective and supportive environment for biopharmaceutical activities; a strong communication infrastructure and quality health care facilities; and a dense population, which enables efficient patient recruitment.